PUBLISHER: The Insight Partners | PRODUCT CODE: 1452638
PUBLISHER: The Insight Partners | PRODUCT CODE: 1452638
The South & Central America poultry diagnostic market is expected to grow from US$ 50.52 million in 2022 to US$ 105.35 million by 2030. It is estimated to grow at a CAGR of 9.6% from 2022 to 2030.
Farm-Side Diagnostic Poultry Platform Fuel South & Central America Poultry Diagnostic Market
Nowadays, a simple farm-side molecular diagnostic platform and complementary surveillance software are installed at the farm site with a high infection rate to curb the spread of disease by test poultry animals for viral and bacterial pathogens. Also, within a short span the poultry industry team can successfully develop a portable, battery-powered, stand-alone diagnostic platform abiding by World Health Organization (WHO) guidelines to ensure that these devices can be operated anywhere on the farm, eliminating the need for laboratory structure, trained personnel, and additional equipment. Also, the cost of the device is 95% lower than comparable commercially available devices and validated against gold standard devices showing equivalent standards. Therefore, implementation of such farm-side poultry disease diagnostic platforms would help farmers keep a check on the spread of infectious disease, antimicrobial resistance (AMR), and zoonotic pathogens by enabling early detection and containment.
South & Central America Poultry Diagnostic Market Overview
The South & Central America Poultry Diagnostics Market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. The market growth in the region is mainly driven by increasing incidence of highly pathogenic avian influenza (HPAI) and rising demand for poultry diagnostics to enhance the quality of food products. The Pan American Health Organization (PAHO) and the World Health Organization (WHO) have confirmed the spread of highly pathogenic avian influenza across Bolivia, Colombia, Costa Rica, Peru, in South & Central America.
South & Central America Poultry Diagnostic Market Revenue and Forecast to 2030 (US$ Million)
South & Central America poultry diagnostic market Segmentation
The South & Central America poultry diagnostic market is segmented into test type, disease, and country.
Based on test type, the South & Central America poultry diagnostic market is segmented into enzyme-linked immunosorbent assay (ELISA) tests, polymerase chain reaction (PCR) tests, hemagglutination-inhibition (HI), and others. The enzyme-linked immunosorbent assay (ELISA) tests segment held the largest share of the South & Central America poultry diagnostic market in 2022.
In terms of disease, the South & Central America poultry diagnostic market is segmented into avian influenza, infectious bronchitis, avian salmonellosis, Newcastle disease, avian mycoplasmosis, and others. The avian mycoplasmosis segment held the largest share of the South & Central America poultry diagnostic market in 2022.
By country, the South & Central America poultry diagnostic market is segmented int o Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America poultry diagnostic market in 2022.
Thermo Fisher Scientific Inc, Idexx Laboratories Inc, Qiagen NV, Eurofins Scientific SE, Boehringer Ingelheim International GmbH, Zoetis Inc, and BioCheck BV are some of the leading companies operating in the South & Central America poultry diagnostic market.